Overview

Denosumab and Osteoporotic Vertebral Compression Fracture

Status:
Recruiting
Trial end date:
2022-09-25
Target enrollment:
Participant gender:
Summary
Evaluation of bone mineral density and function at 1 year after vertebral kyphoplasty for osteoporotic vertebral compression fractures with desomumab intervention: a parallel double-blind randomized controlled clinical trial
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Shenzhen People's Hospital
Treatments:
Denosumab